Visibly reduce the look of lines, crow’s feet, and deep wrinkles with the power of RoC Retinol Correxion Anti-Aging Eye Cream Treatment and Retinol Correxion Deep Wrinkle Night Face Cream. RoC Retinol Correxion Anti-Aging Eye Cream helps moisturize the delicate eye area and helps reduce the appearance of crow’s feet, dark circles, and puffiness. In addition, this nourishing retinol cream is shown to help visibly reduce the appearance of wrinkles around the eyes and crow’s feet in 12 weeks. RoC Retinol Correxion Deep Wrinkle Night Cream visibly reduces the look of lines and deep wrinkles on your face while you sleep. Tested by dermatologists and clinically proven to visibly reduce the look of both fine lines and deep wrinkles in 12 weeks, RoC Retinol Correxion Deep Wrinkle Night Cream is oil-free and non-comedogenic. This anti-aging dual kit, containing pure RoC Retinol, leaves skin feeling smooth and younger-looking.
BOOST YOUR RETINOL WRINKLE REGIMEN: Address 3 key signs of eye aging – puffiness, dark circles & wrinkles – with RoC Eye Cream. Wake up to revitalized, hydrated skin for a smoother, more radiant appearance with RoC Night Cream. Powered by RoC Retinol.
PROVEN RESULTS: Retinol Correxion Night Cream is clinically proven to make your skin look 10 years younger. Retinol Correxion Eye Cream is clinically proven to visibly reduce crow’s feet & wrinkles by 50% in 12 weeks.
ANTI-AGING FORMULAS: Whether you’re looking for a solution for deep wrinkles, fine lines, dark circles, crow’s feet, uneven skin tone or dry skin, we have an anti-aging formula that’s right for you.
SCIENCE & BEAUTY: We produce a wide array of skin care products & treatments including moisturizers, cleansers, serums, skin tone & wrinkle regimens & creams for eyes, neck, décolleté & much more!
SKIN CARE INNOVATION: Our products are recognized by beauty industry leaders & dermatologists for their best-in-class effectiveness. We continue to research & innovate new formulas for healthier skin.
Skin type: Sensitive
Reviews
There are no reviews yet.